Skip to content
10-Q

Quarterly Report

REMEDENT, INC.

0001144204-19-008139

← back to feed
Filed
Feb 14, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Feb 14, 2019 20M sh
Cash And Equivalents Q3 2019 · Dec 31, 2018 $83.49K
Cash And Equivalents Q3 2019 · Mar 31, 2018 $92.88K
Cash And Equivalents Q3 2019 · Dec 31, 2017 $59.3K
Cash And Equivalents Q3 2019 · Mar 31, 2017 $147.11K
Stockholders Equity Q3 2019 · Dec 31, 2018 $2.83M
Stockholders Equity Q3 2019 · Mar 31, 2018 $3.23M
Current Liabilities Q3 2019 · Dec 31, 2018 $2.24M
Current Liabilities Q3 2019 · Mar 31, 2018 $2.13M
Current Assets Q3 2019 · Dec 31, 2018 $784.06K
Current Assets Q3 2019 · Mar 31, 2018 $1.67M
Total Assets Q3 2019 · Dec 31, 2018 $5.13M
Total Assets Q3 2019 · Mar 31, 2018 $5.44M
Shares Diluted Q3 2019 · Dec 31, 2017 20M sh
Shares Diluted Q3 2019 · Dec 31, 2017 20M sh
Operating Cash Flow restated Q3 2019 · Dec 31, 2017 −$28.2K
Eps Diluted Q3 2019 · Dec 31, 2017 $0.00
Eps Diluted Q3 2019 · Dec 31, 2017 $0.01
Eps Basic Q3 2019 · Dec 31, 2017 $0.00
Eps Basic Q3 2019 · Dec 31, 2017 $0.01
Sga Expense Q3 2019 · Dec 31, 2017 $287.03K
Sga Expense Q3 2019 · Dec 31, 2017 $734.83K
Rd Expense Q3 2019 · Dec 31, 2017 $0
Rd Expense Q3 2019 · Dec 31, 2017 $1.86K
Net Income Q3 2019 · Dec 31, 2017 $52.14K
Net Income Q3 2019 · Dec 31, 2017 $164.3K
Operating Income Q3 2019 · Dec 31, 2017 −$23.28K
Operating Income Q3 2019 · Dec 31, 2017 −$62.29K
Gross Profit Q3 2019 · Dec 31, 2017 $541.37K
Gross Profit Q3 2019 · Dec 31, 2017 $1.48M
Cost Of Revenue Q3 2019 · Dec 31, 2017 $203.73K
Cost Of Revenue Q3 2019 · Dec 31, 2017 $734.6K
Revenue Q3 2019 · Dec 31, 2017 $745.1K
Revenue Q3 2019 · Dec 31, 2017 $2.22M